Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001582945-19-000025)

Filing Details

Accession Number:: 0001582945-19-000025
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-09-18 15:12:09
Reporting Period:: 2019-08-28

Accepted Time:: 2019-09-18 15:12:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1425627	Transbiotec Inc.	IMLE	Periodicals: Publishing Or Publishing & Printing (2721)	260731818

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1531111	M Devadatt Mishal	400 N. Tustin Ave. Suite 225 Santa Ana CA 92705		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-28	13,134,420	$0.00	20,534,857	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Reporting Person acquired 13,134,420 shares of the Issuer's common stock in exchange for a $54,478.01 reduction in the amount the Issuer owes the Reporting Person under certain promissory notes. The transaction was documented with a Stock Purchase Agreement and was completed in order to assist the Issuer in complying with the closing conditions of an Asset Purchase Agreement with IDTEC, LLC.